STC2 regulates the proliferation, migration and glycolysis of glioma cells through modulating ITGB2

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Glioma is a prevalent and aggressive primary malignant brain tumor.
• The precise mechanisms driving glioma progression remain incompletely understood.
• Identifying novel molecular targets is crucial for effective glioma treatment.

Purpose of the Study:

• To investigate the functional role and underlying mechanisms of STC2 in glioma.
• To explore the potential interaction between STC2 and ITGB2 in glioma pathogenesis.
• To evaluate the STC2/ITGB2 axis as a potential therapeutic target for glioma.

Main Methods:

• Utilized the Gene Expression Profiling Interactive Analysis (GEPIA) database for gene expression analysis.
• Confirmed the STC2 and ITGB2 interaction using co-immunoprecipitation assays.
• Assessed glioma cell biological functions including proliferation, invasion, migration, and glycolysis via cell counting kit-8, colony formation, Transwell, ELISA, and Western blot assays.

Main Results:

• STC2 was found to be significantly upregulated in glioma samples and cell lines.
• Knockdown of STC2 markedly inhibited glioma cell proliferation, invasion, migration, and glycolysis.
• The interaction between STC2 and ITGB2 was confirmed, and this axis was implicated in regulating glioma cell behaviors.

Conclusions:

• STC2 plays a critical role in promoting glioma progression.
• The STC2/ITGB2 axis is a key regulatory pathway in glioma.
• Targeting the STC2/ITGB2 axis presents a promising therapeutic strategy for glioma treatment.